Meeting Report: Controlled Human Influenza Virus Infection Model Studies: Current Status and Future Directions for Innovation.

Authors: Lane, M. Chelsea¹ (AUTHOR), Luke, Catherine J.¹ (AUTHOR), Bresee, Joseph² (AUTHOR), Dugan, Vivien G.³ (AUTHOR), Post, Diane J.¹ (AUTHOR), Schafer, Julie⁴ (AUTHOR), Roberts, Paul C.¹ (AUTHOR), Wentworth, David E.³ (AUTHOR), Ison, Michael G.¹ (AUTHOR) michael.ison@nih.gov

Source: Influenza & Other Respiratory Viruses. Oct2024, Vol. 18 Issue 10, p1-9. 9p.

Subject Terms: *INFLUENZA vaccines, *VIRUS diseases, *VACCINE development, *COMMUNICABLE diseases, *INFLUENZA viruses

Vaccines for Pandemic Influenza.

Authors: Luke, Catherine J., Subbarao, Kanta

Source: Emerging Infectious Diseases; January 2006, Vol. 12 Issue 1, p66-72, 7p

A Live Attenuated Chimeric West Nile Virus Vaccine, rWN/DEN4Δ30, Is Well Tolerated and Immunogenic in Flavivirus-Naive Older Adult Volunteers

Authors: Pierce, Kristen K., Whitehead, Stephen S., Kirkpatrick, Beth D., Grier, Palmtama L., Jarvis, Adrienne, Kenney, Heather, Carmolli, Marya P., Reynolds, Cynthia, Tibery, Cecilia M., Lovchik, Janece, Janiak, Anna, Luke, Catherine J., Durbin, Anna P., Pletnev, Alexander G.

Source: The Journal of Infectious Diseases, 2017 Jan 01. 215(1), 52-55.

Access URL: https://www.jstor.org/stable/26166793

A 12-Month–Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response

Authors: Durbin, Anna P., Kirkpatrick, Beth D., Pierce, Kristen K., Carmolli, Marya P., Tibery, Cecilia M., Grier, Palmtama L., Hynes, Noreen, Opert, Kari, Jarvis, Adrienne P., Sabundayo, Beulah P., McElvany, Benjamin D., Sendra, Eli A., Larsson, Catherine J., Jo, Matthew, Lovchik, Janece M., Luke, Catherine J., Walsh, Mary C., Fraser, Ellen A., Subbarao, Kanta, Whitehead, Stephen S.

Source: The Journal of Infectious Diseases, 2016 Sep . 214(6), 832-835.

Access URL: http://www.jstor.org/stable/44007159

Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults

Authors: Kirkpatrick, Beth D., Durbin, Anna P., Pierce, Kristen K., Carmolli, Marya P., Tibery, Cecilia M., Grier, Palmtama L., Hynes, Noreen, Diehl, Sean A., Elwood, Dan, Jarvis, Adrienne P., Sabundayo, Beulah P., Lyon, Caroline E., Larsson, Catherine J., Jo, Matthew, Lovchik, Janece M., Luke, Catherine J., Walsh, Mary, Fraser, Ellen A., Subbarao, Kanta, Whitehead, Steven S.

Source: The Journal of Infectious Diseases, 2015 Sep 01. 212(5), 702-710.

Access URL: http://www.jstor.org/stable/43709209

Live Attenuated and Inactivated Influenza Vaccines in Children

Authors: Ilyushina, Natalia A., Haynes, Brenda C., Hoen, Anne G., Khalenkov, Alexey M., Housman, Molly L., Brown, Eric P., Ackerman, Margaret E., Treanor, John J., Luke, Catherine J., Subbarao, Kanta, Wright, Peter F.

Source: The Journal of Infectious Diseases, 2015 Feb 01. 211(3), 352-360.

Access URL: http://www.jstor.org/stable/43708904

A Live Attenuated Influenza A(H5N1) Vaccine Induces Long-Term Immunity in the Absence of a Primary Antibody Response

Authors: Talaat, Kawsar R., Luke, Catherine J., Khurana, Surender, Manischewitz, Jody, King, Lisa R., McMahon, Bridget A., Karron, Ruth A., Lewis, Kristen D. C., Qin, Jing, Follmann, Dean A., Golding, Hana, Neuzil, Kathleen M., Subbarao, Kanta

Source: The Journal of Infectious Diseases, 2014 Jun . 209(12), 1860-1869.

Access URL: http://www.jstor.org/stable/43707574

H5N1 vaccines in humans

Authors: Baz, Mariana, Luke, Catherine J., Cheng, Xing, Jin, Hong, Subbarao, Kanta

Source: In Virus Research 5 December 2013 178(1):78-98

A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial

Authors: Durbin, Anna P., Kirkpatrick, Beth D., Pierce, Kristen K., Elwood, Daniel, Larsson, Catherine J., Lindow, Janet C., Tibery, Cecilia, Sabundayo, Beulah P., Shaffer, Donna, Talaat, Kawsar R., Hynes, Noreen A., Wanionek, Kimberli, Carmolli, Marya P., Luke, Catherine J., Murphy, Brian R., Subbarao, Kanta, Whitehead, Stephen S.

Source: The Journal of Infectious Diseases, 2013 Mar . 207(6), 957-965.

Access URL: http://dx.doi.org/10.1093/infdis/jis936

An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults

Authors: Talaat, Kawsar R., Karron, Ruth A., Luke, Catherine J., Thumar, Bhagvanji, McMahon, Bridget A., Chen, Grace L., Lamirande, Elaine W., Jin, Hong, Coelingh, Kathy L., Kemble, George, Subbarao, Kanta

Source: In Vaccine 12 April 2011 29(17):3144-3148

Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms

Authors: Luke, Catherine J, Subbarao, Kanta

Source: Expert review of vaccines. 13(7):873-883

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100103251603.0x000001&indx=1&recIds=ETOCvdc_100103251603.0x000001

Development of live attenuated influenza vaccines against pandemic influenza strains

Authors: Coelingh, Kathleen L, Luke, Catherine J, Jin, Hong, Talaat, Kawsar R

Source: Expert review of vaccines. 13(7):855-871

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100103251604.0x000001&indx=1&recIds=ETOCvdc_100103251604.0x000001

Borrelia burgdorferi Infection in a Natural Population of Peromyscus Leucopus Mice: A Longitudinal Study in an Area Where Lyme Borreliosis Is Highly Endemic

Authors: Bunikis, Jonas, Tsao, Jean, Luke, Catherine J., Luna, Maria G., Fish, Durland, Barbour, Alan G.

Source: The Journal of Infectious Diseases, 2004 Apr . 189(8), 1515-1523.

Access URL: https://www.jstor.org/stable/30075970

Growth-Inhibiting Antibody Responses of Humans Vaccinated with Recombinant Outer Surface Protein A or Infected with Borrelia burgdorferi or Both

Authors: Luke, Catherine J., Marshall, Margaret A., Zahradnik, John M., Bybel, Michael, Menefee, Barry E., Barbour, Alan G.

Source: The Journal of Infectious Diseases, 2000 Mar 01. 181(3), 1062-1068.

Access URL: https://www.jstor.org/stable/30111420

Influenza virus vaccine composition and methods of use

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults

Authors: Talaat, Kawsar R., Karron, Ruth A., Callahan, Karen A., Luke, Catherine J., DiLorenzo, Susan C., Chen, Grace L., Lamirande, Elaine W., Jin, Hong, Coelingh, Kathy L., Murphy, Brian R., Kemble, George, Subbarao, Kanta

Source: In Vaccine 2009 27(28):3744-3753

An OspA-Based DNA Vaccine Protects Mice against Infection with Borrelia burgdorferi

Authors: Luke, Catherine J., Carner, Kristin, Liang, Xiaowu, Barbour, Alan G.

Source: The Journal of Infectious Diseases, 1997 Jan 01. 175(1), 91-97.

Access URL: https://www.jstor.org/stable/30129998

INFLUENZA VIRUS VACCINE COMPOSITION AND METHODS OF USE

Influenza virus vaccine composition and methods of use

Influenza virus vaccine composition and methods of use